Chimeric antigen receptor‐engineered T cells for immunotherapy of cancer

M Cartellieri, M Bachmann, A Feldmann… - BioMed Research …, 2010 - Wiley Online Library
CD4+ and CD8+ T lymphocytes are powerful components of adaptive immunity, which
essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T cells …

[PDF][PDF] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

M Cartellieri, M Bachmann, A Feldmann, C Bippes… - 2010 - Citeseer
CD4+ and CD8+ T lymphocytes are powerful components of adaptive immunity, which
essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T cells …

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer.

M Cartellieri, M Bachmann… - … of Biomedicine & …, 2010 - search.ebscohost.com
Abstract CD4< sup>+</sup> and CD8< sup>+</sup> T lymphocytes are powerful
components of adaptive immunity, which essentially contribute to the elimination of tumors …

[PDF][PDF] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

M Cartellieri, M Bachmann, A Feldmann, C Bippes… - 2010 - researchgate.net
CD4+ and CD8+ T lymphocytes are powerful components of adaptive immunity, which
essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T cells …

[HTML][HTML] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

M Cartellieri, M Bachmann, A Feldmann… - … of Biomedicine and …, 2010 - ncbi.nlm.nih.gov
Abstract CD4+ and CD8+ T lymphocytes are powerful components of adaptive immunity,
which essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T …

[PDF][PDF] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

M Cartellieri, M Bachmann, A Feldmann, C Bippes… - 2010 - academia.edu
CD4+ and CD8+ T lymphocytes are powerful components of adaptive immunity, which
essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T cells …

[PDF][PDF] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

M Cartellieri, M Bachmann, A Feldmann, C Bippes… - 2010 - pdfs.semanticscholar.org
CD4+ and CD8+ T lymphocytes are powerful components of adaptive immunity, which
essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T cells …

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

M Cartellieri, M Bachmann, A Feldmann… - Journal of Biomedicine …, 2010 - cir.nii.ac.jp
抄録< jats: p>< mml: math xmlns: mml=" http://www. w3. org/1998/Math/MathML">< mml:
mtext> CD</mml: mtext>< mml: msup>< mml: mn> 4</mml: mn>< mml: mo>+</mml …

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

M Cartellieri, M Bachmann, A Feldmann… - BioMed Research …, 2010 - search.proquest.com
Abstract CD [superscript] 4+[/superscript] and CD [superscript] 8+[/superscript] T
lymphocytes are powerful components of adaptive immunity, which essentially contribute to …

[PDF][PDF] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

M Cartellieri, M Bachmann, A Feldmann, C Bippes… - 2010 - cyberleninka.org
CD4+ and CD8+ T lymphocytes are powerful components of adaptive immunity, which
essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T cells …